Results 161 to 170 of about 2,498,124 (314)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer.
J. Lapointe +16 more
semanticscholar +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Gene expression profiling and pathway analysis in acute myeloid leukaemia-normal karyotype patients. [PDF]
Ambayya A +6 more
europepmc +1 more source
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed +10 more
wiley +1 more source
Profiling viral gene expression in lymphomas
Dirk P. Dittmer
doaj +1 more source
Differential gene expression profiling and machine learning-based discovery of key genetic markers in VTE and CKD. [PDF]
Li H, Lin C, Kuang J.
europepmc +1 more source
Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling.
J. Poulin +5 more
semanticscholar +1 more source

